Study of the possibility to prevent the development of Diabetic kidney disease in type 2 diabetic patients
Study of the possible role of the SGLT2 inhibitors to prevent the development of frank type2 DM among prediabetic candidates. Study of the possible role of the SGLT2 inhibitors to prevent the development of diabetic complications, namely diabetic kidney disease, diabetic retinopathy and neuropathy.
Study Type
OBSERVATIONAL
Enrollment
10,000
to study whether the use of gliflozin prevented diabetic complications
prevention of diabetic complications
glomerular filtration rate will be measured at the beginning of the study and at the end
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.